Diagnostic evaluation and management of chronicthromboembolic pulmonary hypertension: A clinical practice guideline;l'évaluation diagnostique et la prise en charge de l'hypertension pulmonaire thromboembolique: Des lignes directrices pour la pratique clinique

Canadian Respiratory Journal

Volumn 17, Issue 6, 2010, Pages 301-334

  Mehta, Sanjay ^a   Helmersen, Doug ^b   Provencher, Steeve ^c   Hirani, Naushad ^b   Rubens, Fraser D ^d   De Perrot, Marc ^e   Blostein, Mark ^f   Boutet, Kim ^f   Chandy, George ^d   Dennie, Carole ^g   Granton, John ^h   Hernandez, Paul ⁱ   Hirsch, Andrew M ^f   Laframboise, Karen ^j   Levy, Robert D ^k   Lien, Dale ^l   Marte, Simon ^j   Shoemaker, Gerard ^a   Swiston, John ^k   Weinkauf, Justin ^l  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSITY HEALTH NETWORK   (Canada)

ⁱ DALHOUSIE UNIVERSITY   (Canada)

^j UNIVERSITY OF SASKATCHEWAN   (Canada)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^l UNIVERSITY OF ALBERTA   (Canada)

more..

Author keywords

Chronic thromboembolic pulmonary hypertension; Clinical practice guideline; Pulmonary endarterectomy; Pulmonary hypertension; Thromboembolism

Indexed keywords

BERAPROST; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; OXYGEN; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; SILDENAFIL; UNIPROST; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL DECISION MAKING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG MEGADOSE; EARLY DIAGNOSIS; ENDARTERECTOMY; EVIDENCE BASED MEDICINE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; LUNG TRANSPLANTATION; LUNG VENTILATION PERFUSION RATIO; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL LITERATURE; OXYGEN THERAPY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING; SURGICAL ANATOMY; SYSTEMATIC REVIEW; VENA CAVA FILTER;

EID: 78650692236     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/704258     Document Type: Article

References (180)

1. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-8.
2. Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 2001;119:818-23.
3. Badesch DB, Abman SH, Ahearn GS, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:35S-62S.
4. McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:78S-92S.
5. Langleben D, Archer S, Granton J, et al. Canadian Cardiovascular Society and Canadian Thoracic Society position statement on pulmonary arterial hypertension. Can Respir J 2005;12:303-15.
6. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV. Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines. Chest 2007;131:1917-28.
7. Barst RJ, Gibbs JS, Ghofrani HA, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S78-S84.
8. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-63.
9. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians Task Force. Chest 2006;129:174-81.
10. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-8.
11. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 1998;158:585-93.
12. Nordstrom M, Lindblad B. Autopsy-verified venous thromboembolism within a defined urban population - the city of Malmo, Sweden. APMIS 1998;106:378-84.
13. Nijkeuter M, Hovens MM, Davidson BL, Huisman MV. Resolution of thromboemboli in patients with acute pulmonary embolism: A systematic review. Chest 2006;129:192-7.
14. Stevinson BG, Hernandez-Nino J, Rose G, Kline JA. Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. Eur Heart J 2007;28:2517-24.
15. Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: One-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 1999;99:1325-30.
16. Ciurzynski M, Kurzyna M, Bochowicz A, et al. Long-term effects of acute pulmonary embolism on echocardiographic Doppler indices and functional capacity. Clin Cardiol 2004;27:693-7.
17. Lund O, Nielsen TT, Schifter S, Roenne K. Treatment of pulmonary embolism with full-dose heparin, streptokinase or embolectomy - results and indications. Thorac Cardiovasc Surg 1986;34:240-6.
18. Remy-Jardin M, Louvegny S, Remy J, et al. Acute central thromboembolic disease: Posttherapeutic follow-up with spiral CT angiography. Radiology 1997;203:173-80.
19. Mastora I, Remy-Jardin M, Masson P, et al. Severity of acute pulmonary embolism: Evaluation of a new spiral CT angiographic score in correlation with echocardiographic data. Eur Radiol 2003;13:29-35.
20. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:259-70.
21. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-72.
22. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-64.
23. Miniati M, Monti S, Bottai M, et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) 2006;85:253-62.
24. Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 2006;130:172-5.
25. Surie S, Gibson NS, Gerdes VE, et al. Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res 2010;125:e202-e205.
26. Klok FA, Zondag W, van Kralingen KW, et al. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med 2010;181:501-6.
27. Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica 2010;95:970-5.
28. Condliffe R, Kiely DG, Gibbs JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008;177:1122-7.
29. Tueller C, Stricker H, Soccal P, et al. Epidemiology of pulmonary hypertension: New data from the Swiss registry. Swiss Med Wkly 2008;138:379-84.
30. Lang IM. Chronic thromboembolic pulmonary hypertension - not so rare after all. N Engl J Med 2004;350:2236-8.
31. Condliffe R, Kiely DG, Gibbs JS, et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33:332-8.
32. Bonderman D, Wilkens H, Wakounig S, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33:325-31.
33. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990;81:1735-43.
34. Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: Clinical picture and surgical treatment. Eur Respir J 1992;5:334-42.
35. Moser KM, Daily PO, Peterson K, et al. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Immediate and long-term results in 42 patients. Ann Intern Med 1987;107:560-5.
36. Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: A follow-up study of the relation between the degree of right ventricle overload and the extent of perfusion defects. J Intern Med 1999;245:601-10.
37. Azarian R, Wartski M, Collignon MA, et al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 1997;38:980-3.
38. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276-315.
39. Lund O, Nielsen TT, Ronne K, Schifter S. Pulmonary embolism: Long-term follow-up after treatment with full-dose heparin, streptokinase or embolectomy. Acta Med Scand 1987;221:61-71.
40. Sharma GV, Folland ED, McIntyre KM, Sasahara AA. Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Vasc Med 2000;5:91-5.
41. The urokinase pulmonary embolism trial. A national cooperative study. Circulation 1973;47:II1-108.
42. Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study. JAMA 1974;229:1606-13.
43. McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001;104:2797-2802.
44. Tumminello G, Lancellotti P, Lempereur M, D'Orio V, Pierard LA. Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure. Eur Heart J 2007;28:569-74.
45. Suntharalingam J, Machado RD, Sharples LD, et al. Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension. Thorax 2007;62:617-22.
46. Wolf M, Boyer-Neumann C, Parent F, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000;15:395-9.
47. Nakamura M, Okada O, Sakuma M, et al. Incidence and clinical characteristics of chronic pulmonary thromboembolism in Japan compared with acute pulmonary thromboembolism: Results of a multicenter registry of the Japanese Society of Pulmonary Embolism Research. Circ J 2002;66:257-60.
48. Tanabe N, Kimura A, Amano S, et al. Association of clinical features with HLA in chronic pulmonary thromboembolism. Eur Respir J 2005;25:131-8.
49. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
50. Lang IM, Klepetko W, Pabinger I. No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH). Thromb Haemost 1996;76:476-7.
51. Wong CL, Szydlo R, Gibbs S, Laffan M. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 2010;21:201-6.
52. Colorio CC, Martinuzzo ME, Forastiero RR, Pombo G, Adamczuk Y, Carreras LO. Thrombophilic factors in chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 2001;12:427-32.
53. Auger WR, Permpikul P, Moser KM. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: A preliminary report. Am J Med 1995;99:392-6.
54. Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003;90:372-6.
55. Jais X, Ioos V, Jardim C, et al. Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 2005;60:1031-4.
56. Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension. J Rheumatol 1998;25:1313-9.
57. Jeremic M, Weisert O, Gedde-Dahl TW. Factor VIII (AHG) levels in 1016 regular blood donors. The effects of age, sex, and ABO blood groups. Scand J Clin Lab Invest 1976;36:461-6.
58. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985;37:89-101.
59. Ignatescu M, Kostner K, Zorn G, et al. Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension. Thromb Haemost 1998;80:231-2.
60. Rosenhek R, Korschineck I, Gharehbaghi-Schnell E, et al. Fibrinolytic balance of the arterial wall: Pulmonary artery displays increased fibrinolytic potential compared with aorta. Lab Invest 2003;83:871-6.
61. Lang IM, Marsh JJ, Olman MA, Moser KM, Schleef RR. Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli. Circulation 1994;90:706-12.
62. Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation 1992;86:1241-8.
63. Lang IM, Marsh JJ, Olman MA, Moser KM, Loskutoff DJ, Schleef RR. Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli. Circulation 1994;89:2715-21.
64. Morris TA, Marsh JJ, Chiles PG, Auger WR, Fedullo PF, Woods VL Jr. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med 2006;173:1270-5.
65. Suntharalingam J, Goldsmith K, van Marion V, et al. Fibrinogen A alpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008;31:736-41.
66. Morris TA, Marsh JJ, Chiles PG, et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 2009;114:1929-36.
67. Bonderman D, Skoro-Sajer N, Jakowitsch J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007;115:2153-8.
68. Jais X, Till SJ, Cynober T, et al. An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: Gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation. Hemoglobin 2003;27:139-47.
69. Chou R, DeLoughery TG. Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. Am J Hematol 2001;67:197-9.
70. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000;111:467-73.
71. Stewart GW, Amess JA, Eber SW, et al. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br J Haematol 1996;93:303-10.
72. Bonderman D, Jakowitsch J, Adlbrecht C, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 2005;93:512-6.
73. Kominami S, Tanabe N, Ota M, et al. HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis. J Hum Genet 2009;54:108-14.
74. Sanchez O, Helley D, Couchon S, et al. Perfusion defects after pulmonary embolism: Risk factors and clinical significance. J Thromb Haemost 2010;8:1248-55.
75. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-48.
76. Tardivon AA, Musset D, Maitre S, et al. Role of CT in chronic pulmonary embolism: Comparison with pulmonary angiography. J Comput Assist Tomogr 1993;17:345-51.
77. Reichelt A, Hoeper MM, Galanski M, Keberle M. Chronic thromboembolic pulmonary hypertension: Evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol 2009;71:49-54.
78. Garg K, Welsh CH, Feyerabend AJ, et al. Pulmonary embolism: Diagnosis with spiral CT and ventilation-perfusion scanning - correlation with pulmonary angiographic results or clinical outcome. Radiology 1998;208:201-8.
79. Falaschi F, Palla A, Formichi B, et al. CT evaluation of chronic thromboembolic pulmonary hypertension. J Comput Assist Tomogr 1992;16:897-903.
80. Heinrich M, Uder M, Tscholl D, Grgic A, Kramann B, Schafers HJ. CT scan findings in chronic thromboembolic pulmonary hypertension: Predictors of hemodynamic improvement after pulmonary thromboendarterectomy. Chest 2005;127:1606-13.
81. King MA, Ysrael M, Bergin CJ. Chronic thromboembolic pulmonary hypertension: CT findings. AJR Am J Roentgenol 1998;170:955-60.
82. Kauczor HU, Schwickert HC, Mayer E, Schweden F, Schild HH, Thelen M. Spiral CT of bronchial arteries in chronic thromboembolism. J Comput Assist Tomogr 1994;18:855-61.
83. Coulden R. State-of-the-art imaging techniques in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:577-83.
84. Kaplinsky EJ, Favaloro RR, Pombo G, et al. Primary pulmonary artery sarcoma resembling chronic thromboembolic pulmonary disease. Eur Respir J 2000;16:1202-4.
85. Kreitner KF, Ley S, Kauczor HU, et al. Chronic thromboembolic pulmonary hypertension: Pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 2004;232:535-43.
86. Kruger S, Haage P, Hoffmann R, et al. Diagnosis of pulmonary arterial hypertension and pulmonary embolism with magnetic resonance angiography. Chest 2001;120:1556-61.
87. Ley S, Kauczor HU, Heussel CP, et al. Value of contrast-enhanced MR angiography and helical CT angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 2003;13:2365-71.
88. Tunariu N, Gibbs SJ, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;48:680-4.
89. Worsley DF, Palevsky HI, Alavi A. Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med 1994;35:793-6.
90. Bergin CJ, Sirlin CB, Hauschildt JP, et al. Chronic thromboembolism: Diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology 1997;204:695-702.
91. Moller HE, Chen XJ, Saam B, et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002;47:1029-51.
92. Moser KM, Rhodes PG, Ufnagel CC. Chronic unilateral pulmonary-artery thrombosis: Successfull thromendarectomy with thirty-month follow-up observation. N Engl J Med 1965;272:1195-9.
93. Houk VN, Hfnagel CA, McClenathan JE, Moser KM. Chronic thrombotic obstruction of major pulmonary arteries. Report of a case successfully treated by thromboendartectomy, and a review of the literature. Am J Med 1963;35:269-82.
94. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993;103:685-92.
95. Skoro-Sajer N, Hack N, Sadushi-Kolici R, et al. Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: A pilot study. Circulation 2009;119:298-305.
96. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006;114:1482-9.
97. Nagaya N, Sasaki N, Ando M, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-43.
98. Bresser P, Fedullo PF, Auger WR, et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:595-600.
99. Jamieson SW. Historical perspective: Surgery for chronic thromboembolic disease. Semin Thorac Cardiovasc Surg 2006;18:218-22.
100. Rubens FD, Bourke M, Hynes M, et al. Surgery for chronic thromboembolic pulmonary hypertension - inclusive experience from a national referral center. Ann Thorac Surg 2007;83:1075-81.
101. Madani MM, Jamieson SW. Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 2006;18:243-9.
102. Kunieda T, Nakanishi N, Satoh T, Kyotani S, Okano Y, Nagaya N. Prognoses of primary pulmonary hypertension and chronic major vessel thromboembolic pulmonary hypertension determined from cumulative survival curves. Intern Med 1999;38:543-6.
103. Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999;160:523-8.
104. Thistlethwaite PA, Mo M, Madani M, Deutsch R, Blanchard D, Kapelanski DP. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2002;124:1203-11.
105. Tscholl D, Langer F, Wendler O, Wilkens H, Georg T, Schafers HJ. Pulmonary thromboendarterectomy - risk factors for early survival and hemodynamic improvement. Eur J Cardiothorac Surg 2001;19:771-6.
106. Mayer E, Dahm M, Hake U, et al. Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 1996;61:1788-92.
107. Hartz RS, Byrne JG, Levitsky S, Park J, Rich S. Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg 1996;62:1255-9.
108. Dartevelle P, Fadel E, Chapelier A, et al. Angioscopic video-assisted pulmonary endarterectomy for post-embolic pulmonary hypertension. Eur J Cardiothorac Surg 1999;16:38-43.
109. Zoia M, D'Armini AM, Beccaria M, et al. Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status. Thorax 2002;57:608-12.
110. Oikonomou A, Dennie CJ, Muller NL, Seely J, Matzinger FR, Rubens FD. Chronic thromboembolic pulmonary arterial hypertension: Correlation of postoperative results of thromboendarterectomy with preoperative helical contrast-enhanced computed tomography. J Thorac Imag 2004;19:67-73.
111. Casaclang-Verdoza G, McCully RB, Oh JK, Miller FA Jr, McGregor CG. Effects of pulmonary thromboendarterectomy on right-sided echocardiographic parameters in patients with chronic thromboembolic pulmonary hypertension. Mayo Clinic Proceed 2006;81:777-82.
112. Mellemkjaer S, Ilkjaer LB, Klaaborg KE, et al. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ten years experience in Denmark. Scand Card J 2006;40:49-53.
113. D'Armini AM, Cattadori B, Monterroso C, et al. Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: Hemodynamic characteristics and changes. Eur J Cardiothorac Surg 2000;18:696-702.
114. Reesink HJ, Tulevski II, Marcus JT, et al. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2007;84:537-43.
115. Mikus PM, Mikus E, Martin-Suarez S, et al. Pulmonary endarterectomy: An alternative to circulatory arrest and deep hypothermia: Mid-term results. Eur J Cardio Thorac Surg 2008;34:159-63.
116. Petrucci L, Carlisi E, Ricotti S, et al. Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: Short-term functional assessment in a longitudinal study. Europa Medicophysica 2007;43:147-53.
117. Tanabe N, Okada O, Nakagawa Y, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J 1997;10:2066-72.
118. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003;76:1457-62.
119. Puis L, Vandezande E, Vercaemst L, et al. Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Perfusion 2005;20:101-8.
120. Matsuda H, Ogino H, Minatoya K, et al. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006;82:1338-43.
121. Ogino H, Ando M, Matsuda H, et al. Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006;82:630-6.
122. Hardziyenka M, Reesink HJ, Bouma BJ, et al. A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. Eur Heart J 2007;28:842-9.
123. Corsico AG, D'Armini AM, Cerveri I, et al. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 2008;178:419-24.
124. Yoshimi S, Tanabe N, Masuda M, et al. Survival and quality of life for patients with peripheral type chronic thromboembolic pulmonary hypertension. Circ J 2008;72:958-65.
125. Iino M, Dymarkowski S, Chaothawee L, Delcroix M, Bogaert J. Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism. Eur Radiol 2008;18:792-9.
126. Ishida K, Masuda M. Thromboendarterectomy for severe chronic thromboembolic pulmonary hypertension. Ann Asian Cardiovasc Thorac 2007;15:229-33.
127. Iwase T, Nagaya N, Ando M, et al. Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension. Heart 2001;86:188-92.
128. Linder J, Jansa P, Kunstyr J, et al. Implementation of a new programme for the surgical treatment of CTEPH in the Czech republic - pulmonary endarterectomy. Thorac Cardiovasc Surg 2006;54:528-31.
129. Menzel T, Kramm T, Mohr-Kahaly S, Mayer E, Oelert H, Meyer J. Assessment of cardiac performance using ten indices in patients undergoing pulmonary thromboendarterectomy. Ann Thorac Surg 2002;73:762-6.
130. Thistlethwaite PA, Madani M, Jamieson SW. Outcomes of pulmonary endarterectomy surgery. Semin Thorac Cardiovasc Surg 2006;18:257-64.
131. Dittrich HC, Nicod PH, Chow LC, Chappuis FP, Moser KM, Peterson KL. Early changes of right heart geometry after pulmonary thromboendarterectomy. J Am Coll Cardiol 1988;11:937-43.
132. Menzel T, Kramm T, Wagner S, Mohr-Kahaly S, Mayer E, Meyer J. Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy. Ann Thorac Surg 2002;73:756-61.
133. Archibald CJ, Auger WR, Fedullo PF. Outcome after pulmonary thromboendarterectomy. Semin Thorac Cardiovasc Surg 1999;11:164-71.
134. Moser KM, Metersky ML, Auger WR, Fedullo PF. Resolution of vascular steal after pulmonary thromboendarterectomy. Chest 1993;104:1441-4.
135. Olman MA, Auger WR, Fedullo PF, Moser KM. Pulmonary vascular steal in chronic thromboembolic pulmonary hypertension. Chest 1990;98:1430-4.
136. D'Armini AM, Cattadori B, Monterroso C, et al. Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: Hemodynamic characteristics and changes. Eur J Cardiothoracic Surg 2000;18:696-702.
137. Matsuda H, Ogino H, Minatoya K, et al. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006;82:1338-43.
138. Ogino H, Ando M, Matsuda H, et al. Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006;82:630-6.
139. Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999;160:523-8.
140. Bergin CJ, Sirlin C, Deutsch R, et al. Predictors of patient response to pulmonary thromboendarterectomy. AJR Am J Roentgenol 2000;174:509-15.
141. Jais X, D'Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008;52:2127-34.
142. Peacock A, Simonneau G, Rubin L. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:608-14.
143. Galie N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009;30:394-403.
144. Suntharalingam J, Treacy CM, Doughty NJ, et al. Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 2008;134:229-36.
145. Bharani A, Mathew V, Sahu A, Lunia B. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. Indian Heart J 2003;55:55-9.
146. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002;347:322-9.
147. Hughes R, George P, Parameshwar J, et al. Bosentan in inoperable chronic thromboembolic pulmonary hypertension. Thorax 2005;60:707.
148. Bonderman D, Nowotny R, Skoro-Sajer N, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2599-603.
149. Ulrich S, Speich R, Domenighetti G, et al. Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study). Swiss Med Wkly 2007;137:573-80.
150. Hoeper MM, Kramm T, Wilkens H, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2363-7.
151. Hughes RJ, Jais X, Bonderman D, et al. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: A 1-year follow-up study. Eur Respir J 2006;28:138-43.
152. Seyfarth HJ, Hammerschmidt S, Pankau H, Winkler J, Wirtz H. Long-term bosentan in chronic thromboembolic pulmonary hypertension. Respiration 2007;74:287-92.
153. Madden BP, Sheth A, Wilde M, Ong YE. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease? Vascul Pharmacol 2007;47:184-8.
154. Rossi R, Nuzzo A, Lattanzi A, Coppi F, Modena MG. Sildenafil improves endothelial function in patients with pulmonary hypertension. Pulm Pharmacol Ther 2008;21:172-7.
155. Sheth A, Park JE, Ong YE, Ho TB, Madden BP. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Vascul Pharmacol 2005;42:41-5.
156. Ghofrani HA, Schermuly RT, Rose F, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003;167:1139-41.
157. Reichenberger F, Voswinckel R, Enke B, et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007;30:922-7.
158. Scelsi L, Ghio S, Campana C, et al. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions. Ital Heart J 2004;5:618-23.
159. Cabrol S, Souza R, Jais X, et al. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2007;26:357-62.
160. McLaughlin VV, Genthner DE, Panella MM, Hess DM, Rich S. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: A case series. Ann Intern Med 1999;130:740-3.
161. Higenbottam TW, Butt AY, Dinh-Xaun AT, Takao M, Cremona G, Akamine S. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart 1998;79:175-9.
162. Skoro-Sajer N, Bonderman D, Wiesbauer F, et al. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost 2007;5:483-9.
163. Lang I, Gomez-Sanchez M, Kneussl M, et al. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest 2006;129:1636-43.
164. Ono F, Nagaya N, Okumura H, et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest 2003;123:1583-8.
165. Ono F, Nagaya N, Kyotani S, Oya H, Nakanishi N, Miyatake K. Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension. Circ J 2003;67:375-8.
166. Vizza CD, Badagliacca R, Sciomer S, et al. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: A case control study. Cardiology 2006;106:168-73.
167. Machherndl S, Kneussl M, Baumgartner H, et al. Long-term treatment of pulmonary hypertension with aerosolized iloprost. Eur Respir J 2001;17:8-13.
168. Reichenberger F, Mainwood A, Doughty N, Fineberg A, Morrell NW, Pepke-Zaba J. Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension. Respir Med 2007;101:217-22.
169. Beyer S, Speich R, Fischler M, Maggiorini M, Ulrich S. Long-term experience with oral or inhaled vasodilator combination therapy in patients with pulmonary hypertension. Swiss Medical Weekly 2006;136:114-8.
170. Aizawa K, Hanaoka T, Kasai H, et al. Long-term vardenafil therapy improves hemodynamics in patients with pulmonary hypertension. Hypertens Res 2006;29:123-8.
171. Perez-Penate GM, Julia-Serda G, Ojeda-Betancort N, et al. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension. J Heart Lung Transplant 2008;27:1326-32.
172. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001;103:10-13.
173. Voorburg JA, Cats VM, Buis B, Bruschke AV. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest 1988;94:1249-53.
174. Christie JD, Edwards LB, Aurora P, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report - 2009. J Heart Lung Transplant 2009;28:1031-49.
175. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54.
176. Hall RJ, Sutton GC, Kerr IH. Long-term prognosis of treated acute massive pulmonary embolism. Br Heart J 1977;39:1128-34.
177. Jerjes-Sanchez C, Ramirez-Rivera A, Arriaga-Nava R, et al. High dose and short-term streptokinase infusion in patients with pulmonary embolism: Prospective with seven-year follow-up trial. J Thromb Thrombolysis 2001;12:237-47.
178. Sharma S, Kashour T, Philipp R. Secondary pulmonary arterial hypertension: Treated with endothelin receptor blockade. Tex Heart Inst J 2005;32:405-10.
179. Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Am J Cardiol 2006;98:525-9.
180. Kourouklis S, Christopoulos A, Liagkas K, Paradellis G, Kyriakides ZS. Bosentan in Eisenmenger syndrome and chronic thromboembolic pulmonary hypertension. Eur J Clin Invest 2006;36(Suppl 3):39-43.